Physician

Anthony Rodman Barber, MD

According to 2025 Medicare claims, Anthony Barber, MD (NPI: 1417926007) practices endocrinology in the Hickory-Lenoir-Morganton, NC market, with the plurality of this provider's patient population coming from Catawba, NC. This provider's primary affiliated billing organization is PIEDMONT ENDOCRINOLOGY, PA (NPI: 1558459602; TIN: 56-1717791) and primary practice location at 28601-3829.

Barber's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 328 traditional Medicare patients, billed 5,336 HCPCS/CPT codes, and received $112,815 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 4,866 prescription claims across 734 beneficiaries totaling $2,487,688 in drug costs, led by Korlym (Mifepristone). DME data shows 619 claims. Open Payments data shows 133 records totaling $462,376. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $831,359 to $2,487,688. For DME billing, reported payments moved from a lower plateau to a higher plateau, from $29,713 to $134,719.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	360	5,207	$123,602
2016	405	5,309	$120,417
2017	421	5,628	$121,146
2018	484	4,649	$112,084
2019	478	4,588	$98,374
2020	515	4,383	$110,924
2021	562	5,933	$155,920
2022	357	3,318	$91,123
2023	353	7,559	$124,930
2024	328	5,336	$112,815

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	385	3,950	$831,359
2016	457	4,296	$1,009,695
2017	467	4,281	$1,129,892
2018	509	4,003	$1,273,896
2019	523	3,735	$1,954,794
2020	537	3,944	$2,047,244
2021	542	3,917	$1,417,747
2022	552	3,686	$1,359,558
2023	608	3,879	$1,848,599
2024	734	4,866	$2,487,688

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	246	750	$50,209
2016	304	826	$51,279
2017	224	650	$73,000
2018	194	678	$82,707
2019	196	636	$79,726
2020	158	636	$101,776
2021	133	706	$138,901
2022	134	601	$115,708
2023	102	575	$123,849
2024	125	619	$151,112

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	123	172	$115
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	189	233	$82
84481	Thyroid hormone, t3 measurement, free	187	272	$17
84443	Blood test, thyroid stimulating hormone (tsh)	214	339	$16
84439	Thyroxine (thyroid chemical), free	214	339	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Korlym	Mifepristone	23	690	$880,820
Ozempic	Semaglutide	112	5,827	$190,740
Mounjaro	Tirzepatide	79	3,232	$115,992
Trulicity	Dulaglutide	92	3,388	$114,808
Jardiance	Empagliflozin	114	5,280	$102,536

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	43	315	$91,831
J1817	Insulin for administration through dme (i.e., insulin pump) per 50 units	N	13	42	$18,339
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	20	57	$13,731
E0784	External ambulatory infusion pump, insulin	Y	N/R	31	$10,641
A4238	Supply allowance for adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	28	$10,558

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	88	$1,697	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	45	$460,679	ABBVIE INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Anthony Rodman Barber, MD?

Tedicare shows public-source Medicare data for Anthony Rodman Barber, MD (NPI 1417926007), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Anthony Rodman Barber, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Anthony Rodman Barber, MD?

Anthony Rodman Barber, MD is linked to PIEDMONT ENDOCRINOLOGY, PA (billing NPI 1558459602) in the available physician profile data.

Does Anthony Rodman Barber, MD have Open Payments data?

Anthony Rodman Barber, MD has 133 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.